FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular, to the field of development of therapeutic and cosmetic compositions and application thereof for delivery of inorganic particles, specifically cerium dioxide nanoparticles, through the skin. A composition for transdermal delivery of nanoparticles is proposed, containing dimethyl sulphoxide as a penetrator and nanocrystalline cerium dioxide as nanoparticles, bound to a stabiliser constituting a polysaccharide, with the following ratio of components, % wt.: cerium dioxide nanoparticles - 1.7; stabiliser - 8.3; dimethyl sulphoxide - 90. Low-molecular polyglucans can be used as a stabiliser.
EFFECT: ensures maximum penetration of cerium dioxide nanoparticles through the skin barrier to a depth of up to 20 mcm.
2 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION BASED ON CERIUM DIOXIDE NANOPARTICLES AND BROWN ALGAE POLYSACCHARIDES FOR TREATING WOUNDS | 2018 |
|
RU2699362C2 |
PEPTIDE TOLEROGENIC COMPOUND | 2021 |
|
RU2766340C1 |
METHOD FOR PRODUCING AN ANTI-INFLAMMATORY AGENT BASED ON MAMMALIAN SPLEEN PEPTIDES, AGENT PRODUCED THEREBY AND APPLICATION THEREOF | 2021 |
|
RU2790158C1 |
METHOD OF PRODUCING STABLE AQUEOUS COLLOIDAL SOLUTIONS OF CERIUM DIOXIDE NANOPARTICELS | 2016 |
|
RU2615688C1 |
MICROEMULSIVE COMPOSITIONS FOR CREATION OF TRANSDERMAL AND TRANSMUCOSAL FORMS OF PHARMACEUTICAL MEDICATIONS AND COSMETIC PREPARATIONS, AND METHOD OF THEIR APPLICATION | 2012 |
|
RU2481822C1 |
METHOD FOR PREPARING STABILISER-COATED NANOCRYSTALLINE CERIUM DIOXIDE | 2012 |
|
RU2484832C1 |
METHOD FOR PRODUCING A BIOLOGICALLY ACTIVE COMPOSITE BASED ON NANOCRYSTALLINE CERIUM DIOXIDE AND CURCUMIN | 2017 |
|
RU2665378C1 |
TRANSDERMAL PLASTER | 2019 |
|
RU2705896C1 |
METHOD FOR OBTAINING A CERIUM DIOXIDE SOL IN A NON-AQUEOUS MEDIUM | 2022 |
|
RU2798099C1 |
SYSTEM OF TRANSDERMAL TRANSFER ENHANCERS AND COSMETIC COMPOSITIONS BASED THEREON | 2020 |
|
RU2736504C1 |
Authors
Dates
2021-08-19—Published
2021-01-26—Filed